Summary by Moomoo AI
CHINA BIOPHARMACEUTICAL CO., LTD. ANNOUNCED THAT IT WILL HOLD A BOARD MEETING ON THURSDAY, MARCH 28, 2024. THE PRIMARY PURPOSE OF THE MEETING IS TO APPROVE AND ANNOUNCE THE ANNUAL RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED 31 DECEMBER 2023, AND CONSIDERATION WILL BE GIVEN TO THE PROPOSED DISTRIBUTION OF A FINAL DIVIDEND. THE MEETING WAS NOTIFIED ON 1 MARCH 2024 BY THE COMPANY SECRETARY, CHAN KAI NIN. Currently, the Board of Directors of China Biopharmaceuticals consists of seven executive directors and five independent non-executive directors.